http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-8400629-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9433d383d1922b3df0ca6c182c7d3925
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-00
filingDate 1984-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16867a61eb0d75c5ec3c60ab63854c5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4620ed9514589e3eb827201367898dcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_611a5a103ffe76f083d62f7ee76d7829
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1295d65213919c9b268f4f2d4e5312d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7042353f0e3da0202914edd2bde91c1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f7b4d992b7e80e57f1b6d6bba9a083c
publicationDate 1984-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SE-8400629-L
titleOfInvention BASIC OXIMETERS
abstract The invention relates to selected stereoisomers having the E, E or E, Z configuration and within the Formula (I) <IMAGE> (I) wherein N is 2-4, A is alkylene or 2 or 3 carbon atoms, R is phenyl or substituted phenyl and R1 and R2 are lower alkyl, or, together with the carbon to which attached, form a heterocyclic ring; and pharmaceutically acceptable acid addition salts thereof, a process for their preparation and pharmaceutical compositions comprising the same. The compounds of the general formula (I) can be used in therapy due to their narcosis potentiating, analgesic and antiarrhythmial effect.
priorityDate 1983-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 31.